C200-0506 Screening compound: 3-amino-4-(4-bromophenyl)-N5-(4-chlorophenyl)-N2-[2-(cyclohex-1-en-1-yl)ethyl]-6-methylthieno[2,3-b]pyridine-2,5-dicarboxamide

C200-0506 Screening compound: 3-amino-4-(4-bromophenyl)-N5-(4-chlorophenyl)-N2-[2-(cyclohex-1-en-1-yl)ethyl]-6-methylthieno[2,3-b]pyridine-2,5-dicarboxamide
C200-0506 Screening compound: 3-amino-4-(4-bromophenyl)-N5-(4-chlorophenyl)-N2-[2-(cyclohex-1-en-1-yl)ethyl]-6-methylthieno[2,3-b]pyridine-2,5-dicarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C200-0506
3-amino-4-(4-bromophenyl)-N5-(4-chlorophenyl)-N2-[2-(cyclohex-1-en-1-yl)ethyl]-6-methylthieno[2,3-b]pyridine-2,5-dicarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C200-0506

Molecular Formula

C30H28BrClN4O2S (C30 H28 BrClN4 O2 S)

Compound Name

3-amino-4-(4-bromophenyl)-N5-(4-chlorophenyl)-N2-[2-(cyclohex-1-en-1-yl)ethyl]-6-methylthieno[2,3-b]pyridine-2,5-dicarboxamide

IUPAC name

3-amino-4-(4-bromophenyl)-N5-(4-chlorophenyl)-N2-[2-(cyclohex-1-en-1-yl)ethyl]-6-methylthieno[23-b]pyridine-25-dicarboxamide

SMILES

Cc1nc(sc(C(NCCC2=CCCCC2)=O)c2N)c2c(-c(cc2)ccc2Br)c1C(Nc(cc1)ccc1Cl)=O

InChI

InChI=1S/C30H28BrClN4O2S/c1-17-23(28(37)36-22-13-11-21(32)12-14-22)24(19-7-9-20(31)10-8-19)25-26(33)27(39-30(25)35-17)29(38)34-16-15-18-5-3-2-4-6-18/h5,7-14H,2-4,6,15-16,33H2,1H3,(H,34,38)(H,36,37)

InChI Key

JMBPKWUYVDDUQA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD26961466

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

624

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

7.591

Distribution Coefficient, logD

7.587

Water Solubility, LogSw

-6.66

Polar Surface Area

77.189

Acid Dissociation Constant (pKa)

9.53

Base Dissociation Constant (pKb)

3.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.30

C200-0506 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C200-0506 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C200-0506?
Check Price and Availability of C200-0506, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C200-0506 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C200-0506
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C200-0506
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C200-0506 available by request